Apoptotic death of autoreactive lymphocytes constitutes a major mechanism of immunological tolerance. Defects in the deletion of autoreactive Tand B lymphocytes, either in primary lymphoid organs [1] [2] [3] or in the periphery, 2 can lead to autoimmune disease. The 'death receptor' FAS (CD95, APO-1), and its ligand FASL (CD95L, APO-1L), has critical roles in the removal of autoreactive lymphocytes in the periphery, 4 and in contraction of immune responses and lymphocyte homeostasis. 5 Accordingly, loss-of-function mutations in these genes cause lymphadenopathy and systemic lupus erythematosus (SLE)-like multiorgan autoimmune disease in mice 6 and humans. 7 FAS, which is expressed on the surface of many cell types, allows FASL-mediated killing of pathogen-infected or damaged cells, 4 whereas its ligand (FASL) is thought to be present only on activated T cells and NK cells. 4 Upon deposition in the plasma membrane, membrane-bound FASL (mFASL) can also be processed and shed as secreted FASL (sFASL). 4 The generation of mice that lack mFASL but express sFASL (FasL Δm/Δm ) demonstrated unambiguously that only the former is essential for FAS-mediated cell killing, activationinduced T-cell death (AICD) and lymphocyte homeostasis. 8 
Although FasL
Δm/Δm mice lack functional mFASL, they can still produce sFASL, which can engage FAS, an interaction postulated to trigger non-apoptotic signals, 4, 9 which promote inflammation and cytokine production. 8, 10 Consistent with this hypothesis, FasL Δm/Δm mice develop SLE-like kidney disease, autoimmune allergic dermatitis and histiocytic sarcoma with higher incidence and accelerated rate compared with FasL gld/gld mice, 8 which carry a mutation that impairs the function of both mFASL and sFASL.
The onset of disease in FasL Δm/Δm mice is preceded by an elevation in immune cells with activated nuclear factor-κB (NF-κB) that coincides with elevated serum levels of NF-κB-regulated inflammatory cytokines. 8 The NF-κB family of transcription factors, comprising homodimers and heterodimers of the five related proteins RELA, RELB, c-REL, NF-κB1 (p105/p50) and NF-κB2 (p100/p52), regulates the development, survival and function of innate and adaptive immune cells. 11, 12 Different NF-κB dimers retained in a latent cytoplasmic state by various IκB inhibitory proteins are differentially activated by the canonical and non-canonical arms of the NF-κB pathway in response to distinct upstream signals (Supplementary Figure S1) . 13 Antigen receptors and inflammatory cytokines, such as TNF, IL-1β and IL-6, are among the many signals that activate the canonical NF-κB transcription factors (dimers of c-REL or RELA and p50/NF-κ B1 11, 12 ) through IKKβ-dependent proteasome-mediated degradation of IκB inhibitory proteins (Supplementary Figure  S1) . Conversely, certain TNF receptor family members (e.g., BAFF-R) trigger the non-canonical NF-κB pathway through IKKα-induced proteolysis of p100/NF-κB2 bound to RELB, thereby generating dimers of p52/NF-κB2 and RelB (Supplementary Figure S1) . 11, 12 Canonical and noncanonical NF-κB transcription factors generally control different sets of genes, 14 although a subset of genes is co-regulated by the two arms of the NF-κB pathway.
Abnormally elevated NF-κB activity features in various human autoimmune diseases, including SLE and rheumatoid arthritis, 12, 15, 16 where it is thought to drive pathology by regulating the proliferation, survival and effector activities of immune cells. [16] [17] [18] [19] The functions that NF-κB-regulated transcriptional programs exert in the immune system, combined with our findings that leukocytes in FasL Δm/Δm mice have abnormally elevated NF-κB activity before disease onset, led us to investigate whether NF-κB signaling is critical for this disease. Due to the profound deleterious consequences associated with systemic NF-κB inhibition, 20 we focused on investigating the impact of selective loss of c-REL or NF-κB2 on autoimmune pathology in FasL Δm/Δm mice. These NF-κB transcription factors were chosen because of their selective function in the canonical or non-canonical NF-κB pathways, and because they are mainly required for immune cell function and not for embryogenesis or hematopoietic cell development. Mice lacking c-REL, which is mainly expressed in hematopoietic cells, 21 have no major abnormality but exhibit defective activation of B and T lymphocytes, macrophages and DC that collectively contribute to reduced antibody and cytokine production. 12, 22, 23 In nfkb2 − / − mice, T-cell and myeloid cell development and functions are intact, but reduced mature B-cell numbers due to their impaired survival, combined with germinal center defects, result in reduced humoral immune responses. 24, 25 Interestingly, with age, nfkb2 − / − mice exhibit multiorgan leukocyte infiltrates and mild autoimmune disease. 18, 26 Our study demonstrates that loss of c-REL prevents autoantibody production in FasL Δm/Δm mice and thereby substantially prolongs their lifespan. This suggests that selective targeting of c-REL may represent a promising strategy for the treatment of systemic autoimmune diseases.
Results

Loss of c-REL extensively prolongs the lifespan of FasL
Δm/Δm mice, whereas loss of NF-κB2 has only a modest impact. To investigate the roles of the canonical or non-canonical NF-κB signaling pathways in the lymphadenopathy and autoimmune disease caused by defects in FASL, we intercrossed FasL Δm/Δm animals with c-rel − / − or nfkb2 − / − and wt versus c-rel − / − both P = NS, Figure 1a ). Loss of NF-κB2 only modestly (P = 0.0344) prolonged the lifespan of FasL Δm/Δm mice, whereas this was greatly extended by loss of c-REL (Po0.0001, Figure 1a) .
The morbidity and premature death of FasL Δm/Δm mice are due to lymphadenopathy and SLE-like autoimmune glomerulonephritis (GN, Figure 1b) . 8 Histological examination (Figure 1c ) and immunostaining for glomerular immune complex deposition indicated that the incidence of severe autoimmune kidney damage was significantly reduced in both FasL Δm/Δm c-rel − / − and FasL Δm/Δm nfkb2 − / − mice, and the damaging immunoglobulin deposition on the glomerular capillary loops (Figure 1d , arrows) in these animals was now mainly confined to mesangial cells (Figure 1d) . Impairment of renal function (pathology grading 3-4) was modest and delayed in FasL
Δm/Δm , Po0.05). Loss of c-REL had a more profound impact on GN-associated autoimmune pathology (P = 0.0002), manifest as substantial reductions in hypercellularity, capillary loop obliteration and fibrinoid necrosis (Figures 1b and c) .
NF-κB2 and c-REL are required for inflammatory cytokine production in FasL Δm/Δm mice. Before the onset of SLE-like autoimmune disease (~5 months), FasL Δm/Δm mice harbor high levels of circulating inflammatory cytokines. 8 We examined the levels of 31 cytokines and chemokines and found that TNF, IL-17A/F, KC (CXCL1) and MIP-1β levels were elevated in FasL Δm/Δm mice at 5 months of age (Figure 2a ), whereas IFNβ remained largely undetectable by ELISA (Supplementary Figure S2) , although type I interferons have been implicated previously in the GN in Fas lpr/lpr mutant mice. 27 NF-κB2 deficiency blunted the excess production of most cytokines (except KC) in FasL Δm/Δm mice ( Figure 2a ). As FasL Δm/Δm mice aged, IL-1β and IL-6 levels increased significantly, whereas in aged FasL
Δm/Δm
nfkb2
− / − mice (283-683 days) all cytokines tested, with the exception of IL-17A/F and KC, remained at wt levels ( Figure 2b ). Remarkably, none of the cytokines or chemokines tested were elevated in FasL Δm/Δm c-rel − / − mice, even when aged (Figures 2a and b) . This indicates that c-REL and, to a lesser extent, NF-B2 are required for accumulation of the cytokines and chemokines associated with autoimmune pathology in FasL Δm/Δm mice.
NF-κB2 restrains lymphadenopathy in FasL
Δm/Δm mice. Defects in AICD of T cells are a major cause of lymphadenopathy in mice and humans deficient in FASL/FAS function and are associated with the accumulation of 'unusual' TCRαβ
FasL Δm/Δm mice display lymphadenopathy and splenomegaly commencing from~3 months of age (Figures 3a and b) . Surprisingly, loss of NF-κB2 greatly accelerated lymphadenopathy in FasL Δm/Δm mice (Figures 3a and b) with a fourfold increase in DN T cells compared with FasL Δm/Δm controls ( Figure 3c ). By 3 months, these DN T cells comprised the majority of leukocytes in the lymph nodes (81.9 ± 2.8%) and spleens of FasL Δm/Δm nfkb2 − / − mice (76.7 ± 1.1%, Figure 3c ), resulting in a 410-fold increase in total lymph node and splenic cellularity compared with FasL Δm/Δm mice ( Figure 3e ). In contrast, loss of c-REL had no impact on the onset or magnitude of lymphadenopathy and DN T-cell numbers in FasL Δm/Δm mice (Figures 3a-e) . To assess whether the enhanced lymphadenopathy of FasL Δm/Δm nfkb2 − / − mice was intrinsic to the hematopoietic system, bone marrow chimeras were generated. C57BL/6-Ly5.1 (wt) mice reconstituted with hematopoietic stem/progenitor cells (HSPCs) from FasL Figure S4) . Remarkably, the sera of FasL
Δm/Δm c-rel
mice remained ANA negative (Figures 3g-i) .
To determine whether lymphocytic tissue infiltration, another feature of the autoimmune pathology in FasL Δm/Δm mice, 8 was associated with the production of organ-specific autoantibodies, we assessed the reactivity of sera from sick Table 1 ).
The roles of NF-κB2 and c-REL in autoimmune pathology in FasL
Δm/Δm mice. To further understand how NF-κB2 and c-REL influence the early phase of autoimmune pathology in FasL Δm/Δm mice, we examined the lungs, liver, salivary glands and pancreas at 5 months. Although lung disease was not apparent in FasL Δm/Δm mice, severe peribronchial and perivascular lymphocytic infiltrates were prominent in 
c-rel
− / − mice showed a similar incidence of this disease (39%), albeit with delayed onset compared with the FasL Δm/Δm animals (660 ± 134 days versus 435 ± 86 days) (Figures 4f and h ). Dermatitis in FasL Δm/Δm and FasL Δm/Δm c-rel − / − mice was associated with elevated serum IgE levels (Figure 4g and O'Reilly et al. 8 ), a feature shared with humans suffering from this autoimmune pathology. 29 These findings show that loss of c-REL merely delayed autoimmune dermatitis in FasL Δm/Δm mice, whereas loss of NF-κB2 abrogated this pathology.
Regulatory T cells (Tregs) have a key role in the suppression of autoimmunity and modulation of the intensity and quality of immune responses to foreign antigens. 30 Of relevance to this study, reductions in Treg numbers or impaired Treg function have been implicated in murine and human autoimmune dermatitis. 31, 32 (Figure 5b) . However, consistent with a previous report 33 showing that loss of c-REL resulted in a substantial reduction in Tregs, both the percentages and absolute numbers of Tregs in FasL Δm/Δm c-rel − / − mice were markedly reduced compared with FasL Δm/Δm and wt animals (Figures 5a and b) . These results, combined with the impact that NF-κB2 or c-REL loss had on the phenotype in FasL Δm/Δm mice, indicate that while Treg defects are not likely to be critical for the development of autoimmune pathology in these animals reduction in Treg numbers may explain in part the dermatitis seen in the FasL
NF-κB2 but not mFASL or c-REL is required for the development of AIRE+ mTECs. The epithelial components of the thymic stroma have critical roles in promoting central tolerance to tissue-specific antigens. 34 A reduction in the number or function of medullary thymic epithelial cells (mTECs) is linked to T-cell-dependent inflammatory diseases triggered by autoreactive T cells that escape negative selection. 34, 35 Both the canonical and non-canonical NF-κB pathways have been implicated in tolerogenic processes mediated by the thymic stroma, 36 with the non-canonical pathway reported to be important for the differentiation and/or survival of mTECs. 34 NF-κB2 deficiency was associated with a loss of CD80 + mTEC, but not the reduction of mTECs that express the autoimmune regulator (AIRE). 18 We conducted a detailed analysis of the thymic microenvironment to examine whether mTEC defects might be responsible for the organspecific autoimmunity observed in FasL Δm/Δm mice or for the alterations in the FasL Δm/Δm disease profile exerted by loss of NF-κB2 or c-REL (summarized in Table 2 ).
Thymi from 6-or 20-week-old FasL Δm/Δm mice stained for mTEC markers (keratin-5 (K5), UEA-1 and AIRE) displayed a medullary architecture comparable to that of age-matched wt mice, although the levels of UEA-1 may be lower (Figures 6a  and b) . The expression of mTEC markers in the thymi of c-rel − / − and FasL Δm/Δm c-rel − / − mice was also normal (Figures  6a and b) . In contrast, thymi from nfkb2 − / − and FasL (Figure 6f ). In summary, although FasL Δm/Δm mice display many features of autoimmune disease, they have a normal TEC composition, indicating that mFASL has no major role in TEC development and survival. Loss of AIRE expressing mTECs, however, correlates with impaired negative selection and multiorgan autoimmunity 34 and this may provide an explanation for the mild age-related autoimmunity 
Discussion
The many roles of canonical and non-canonical NF-κB signaling in the immune system identify constituents of these pathways as potential therapeutic targets for inflammatory and autoimmune diseases. Indeed, the immunosuppressive and anti-inflammatory activity of glucocorticoids, a treatment of choice for many autoimmune diseases, is at least in part due to attenuated NF-κB signaling. 20 However, as NF-κB signaling regulates a wide variety of biological processes both within and outside the immune system, prolonged blockade of overall NF-κB activity, not surprisingly, can cause severe adverse effects. 37 Accordingly, we assessed whether targeting individual NF-κB transcription factors would be a superior strategy for treating autoimmune disease. FasL Δm/Δm mice were used as a model to determine the impact that the loss of c-REL (canonical pathway) or NF-κB2 (non-canonical pathway) had on their multifaceted autoimmune pathology. The largely hematopoietic restricted expression of c-REL 21 offers the added advantage of primarily targeting immune functions. 22 Notably, targeting the canonical pathway in T cells using a proteasome degradation resistant form of IκBα(IκB) afforded only minor protection from autoimmune disease in FasL gld/gld mice. 38 However, given that NF-κB signaling was only diminished, not abrogated, combined with the essential loss of FAS function in B cells in this autoimmune disease, 39 the full impact of completely inhibiting a particular NF-κB transcription factor on autoimmune disease caused by defects in FASL/FAS remains unclear. Our study is the first detailed, long-term analysis of the roles that specific NF-κB family members have in the autoimmune disease caused by defects in FASL/FAS.
With respect to non-canonical NF-κB signaling, loss of NF-κB2 had contrasting impacts on different aspects of the FasL Δm/Δm autoimmune disease. Autoantibody-mediated pathologies (dermatitis and severe GN) were reduced but the lymphoproliferative disease was enhanced, causing respiratory difficulties and multiorgan vasculitis. This establishes that NF-κB2-dependent signals restrain proliferation and/or survival of the lymphocytes that accumulate to excess as a consequence of defective FASL/FAS-mediated apoptosis. Our studies using chimeric mice indicate that NF-κB2 activity within the hematopoietic system is mainly responsible for restraining the proliferation and/or survival of these T lymphocytes, although non-hematopoietic functions regulated by NF-κB2 may contribute. The NF-κB2 precursor p100, a protein with IκB-like activity, 40 limits NF-κB-dependent T-cell proliferation by preventing the nuclear activation of p50-NF-κB1/p65 heterodimers. 41 The absence of this inhibitory p100-NF-κB2 protein may be a mechanism that contributes to the increased accumulation of T cells in FasL Δm/Δm autoimmune disease associated with NF-κB2 loss can be explained by reduced BAFF-R survival signals in B cells and/or germinal center defects, both of which involve p52-NF-κB2/RELB dimers. 19 Overall, these findings suggest that, while systemic therapeutic targeting of NF-κB2 could alleviate autoantibody-induced pathology, this benefit would be negated by enhanced lymphoproliferative disease.
Our study also provides insight into the role of NF-κB2 in autoimmune dermatitis. Unlike FasL Δm/Δm mice that develop IgE-dependent autoimmune dermatitis, the FasL Δm/Δm nfkb2 − / − mice were protected. Consistent with NIK, the apical kinase in the non-canonical NF-κB2-dependent pathway 42 being critical for isotype switching to IgE, 42 our aged nfkb2 − / − mice had~100-fold lower serum IgE levels compared with wt controls, and even in FasL Δm/Δm nfkb2 − / − mice the serum IgE levels were still below those found in wt mice. Given that topical delivery of NF-κB decoy oligodeoxynuclotides alleviates murine atopic dermatitis, 43 our findings indicate that topical NF-κB2 inhibitors may represent a promising strategy for treating IgE-dependent autoimmune dermatitis. In contrast to a prior report, which showed that isotype switching to IgE was c-REL dependent, 44, 45 we found that IgE levels were not markedly reduced by loss of c-REL on either a wt or a FasL Δm/Δm background. The reason for these differences remains to be determined.
This report demonstrates that c-REL loss substantially prolongs the lifespan of FasL Δm/Δm mice by preventing autoantibody-mediated pathology. Although c-REL is critical for normal T-cell activation through a combination of T-cell intrinsic and extrinsic processes, 12, 22, 28 lymphadenopathy was unaffected by loss of c-REL. This indicates that the accumulation of DN T cells is driven by other NF-κB proteins or is NF-κB independent. This disjunction between extended lifespan despite persistence of the lymphoproliferative component of the autoimmune disease elicited by defects in FASL/ FAS is consistent with studies of gene-targeted mice lacking FAS in select cell populations. 39 Loss of c-REL has also been shown to prevent pathology in mouse models of collageninduced arthritis, 46 streptozotocin-induced diabetes 47 and autoimmune encephalomyelitis. 48 These outcomes can be explained by the involvement of Th1 cytokines and/or IL-17 in these diseases, because their production and the differentiation of Th1, 49 as well as Th17 48 effector T cells, are c-RELdependent. The fact that c-REL is also critical for cytokine production by macrophages, dendritic cells and NKT cells 12 is also likely to contribute to the reduced pathology in FasL 27 However, no data on animal lifespan were provided and these mice were on a mixed genetic background; notably, genetic background greatly affects pathology in Fas lpr/lpr mice. Thus, the role of type I interferons in SLE-like disease in mice with defects in FASL or FAS remains unclear.
A requirement for c-REL in antigen receptor-induced T-and B-cell activation 23 is the most likely explanation for why the reduction in Treg numbers, caused by the loss of c-REL, 33 neither exacerbates autoimmune disease in FasL Δm/Δm c-rel
mice nor instigates autoimmunity in c-rel − / − mice. 23 Interestingly, mice deficient for PELI1, 50 a unbiquitin E3-ligase that controls c-REL levels, develop an autoimmune phenotype similar to those observed in FasL Δm/Δm mice, accompanied by nuclear accumulation of c-REL and excessive canonical NF-κB activation. As PELI1 appears to be critical for the maintenance of T-cell tolerance, it would be interesting to test whether c-REL dysregulation, specifically in T cells, is responsible for the SLElike autoimmune disease in FasL Δm/Δm mice. In conclusion, our studies using FasL Δm/Δm mice demonstrate that the canonical and non-canonical NF-κB pathways have critical, yet distinct roles in autoimmune and lymphoproliferative pathology. Although autoimmune diseases caused by inherited mutations in FASL or FAS (ALPS patients) are rare, subtle abnormalities in this apoptotic pathway arising from gene polymorphisms are likely to contribute to autoimmune disease predisposition more generally. 51 Combined with the recent discovery of links between polymorphisms in c-Rel and increased susceptibility to certain human autoimmune diseases, 23 our findings suggest that targeting c-REL constitutes an attractive strategy to alleviate or prevent autoimmune pathology, while avoiding the major side effects associated with pan-NF-κB inhibition.
Materials and Methods
Mice. All animal experiments were approved by the Walter and Eliza Hall Institute Animal Ethics Committee. FasL Δm/Δm mice were generated on a C56BL/6 genetic background.
8 nfkb2 − / −25 and c-rel − / − mice 22, 28 were generated on a mixed C57BL/6x129SV background and backcrossed onto a C57BL/6 background for 410 generations. FasL Δm/Δm mice were intercrossed with nfkb2 − / − or c-rel 
Δm/Δm , nfkb2 − / − and c-rel − / − mice used in this study were maintained within the same colony.
Histological analysis and scoring. Mice were killed by CO 2 asphyxiation. Organs were removed and fixed in 80% Histochoice (Amresco, Solon, OH, USA) or 10% buffered formalin and paraffin embedded. Histological examination was performed by staining with hematoxylin and eosin (H&E). H&E-stained sections of the kidneys were examined for evidence of GN and scored on a scale of 0-4 (0 = normal; 1 = minor mesangial hypercellularity; 2 = moderate hypercellularity; 3 = severe hypercellularity; 4 = severe hypercellularity with obliteration and thickening of all capillary loops or the presence of fibrinoid necrosis or glomerular crescents). Lymphoid infiltration into organs (lung, liver, pancreas, submandibular gland and stomach) was assessed by examining H&E-stained sections and graded 0-3 (0= none; 1 = occasional small perivascular foci (age related); 2 = more dense, well-defined perivascular and periductal foci; 3 = extensive infiltrate with parenchymal destruction). Organs were also examined and scored for the presence of necrotizing vasculitis. All photomicrographs were acquired using a × 10/NA 0.3, × 20/NA 0.50 or × 40/NA 0.75 objective lens attached to an Axioplan 2 microscope (Carl Zeiss, North Ryde, NSW, Australia).
Immunofluorescent staining and confocal microscopy. The presence of autoantibodies against classical target tissues in autoimmune diseases (salivary gland, lacrimal gland, eye, kidney, liver, lung, pancreas, stomach and thyroid) was assessed by staining frozen tissue sections (5 μm, air dried and fixed in acetone) of rag-1 − / − mice (to eliminate endogenous Ig, a source of background staining) with sera (1/100 dilution) from aged or sick mice. Staining was detected with FITC conjugated goat antibodies against mouse IgG, IgA or IgM (Cappel (MP Biochemicals), Santa Ana, CA, USA). To stain for immune complex deposits, the kidneys from aged or sick mice were snap-frozen in isopentane, sectioned, acetone fixed, and blocked with PBS/2% FCS, followed by staining with FITC-coupled goat antibodies specific to mouse IgM, IgG or IgA (Southern Biotechnology, Birmingham, AL, USA). All immunofluorescent staining was analyzed using a Leica laser scanning (SP2) confocal microscope.
Frozen sections of thymi from 6-or 20-week-old mice were cut at − 20°C on a cryostat (5 μm), air dried and fixed in acetone. Sections were incubated with primary mAbs in 0.5%FCS/PBS for 30 min in a moist chamber, washed three times in PBS and incubated, while protected from light, with the appropriate secondary Abs plus DAPI, followed by washing. Primary Abs included biotin-conjugated anti-UEA-1 (Vector Laboratories, Burlingame, CA, USA), rabbit anti-keratin-5 (MK5, Covance, Biolegend, San Deigo, CA, USA) and Alexa 405-conjugated anti-AIRE. Detection was achieved using Alexa Fluor 555-conjugated goat anti-rabbit IgG antibodies or FITCconjugated Streptavidin (both from Invitrogen, Carlsbad, CA, USA). Staining was analyzed using a Zeiss LSM5 line scanning confocal microscope (Carl Zeiss).
ANA in sera from aged or sick mice was detected by staining (1/100 serum dilution) of slides coated with HEp-2 human epithelial cells according to the manufacturer's instructions (Immuno Concepts, Sacramento, CA, USA) and detected with FITCconjugated rabbit antibodies against all mouse Igs (Cappel (MP Biochemicals)) or FITC-conjugated rabbit antibodies selective for mouse IgM, IgG or IgA (Southern Biotechnology). ANA levels were quantified according to the brightness of fluorescence intensity on a scale of 0 (no fluorescence) to 3+ (maximum fluorescence intensity). Serum ANA levels were also measured by ELISA (The Binding, Site, Birmingham, UK) according to the manufacturer's instructions.
Hematopoietic reconstitution. Ablation of the hematopoietic compartment was achieved by exposing mice to two doses of 5.5 Gy of γ-irradiation from a 60 Co source, 2 h apart. Irradiated mice were reconstituted by intravenous (i.v.) injection of 10 6 total bone marrow cells in a 100 μl volume of PBS. Reconstituted mice were maintained on 2 mg/ml neomycin-supplemented water for 21 days.
Flow cytometric analysis of thymic stromal cell populations. This procedure was adapted from previously described protocols. 52, 53 Thymi were processed individually for digestion as described. 53 First, thymi were cleaned of fat and connective tissue, the lobes separated and the capsule nicked with fine scissors. Thymi were then individually agitated in 10 ml RPMI-1640 medium for several minutes to gently flush out thymocytes using a wide-bore pipette. The remaining thymic tissue was then incubated at 37°C for 15 min in 1 ml of Liberase/ DNAase I (0.5 units and 0.1%, respectively, both from Roche, Germany) in RPMI-1640 medium with regular agitation, as detailed. 54 Fragments were allowed to settle and the supernatant was collected (fraction 1), kept on ice and the digestion process repeated with the settled thymic fragments. After a second digestion (fraction 2), the remaining aggregates were centrifuged, and resuspended in PBS with 5 mM EDTA, 2% FCS and 0.02% NaN 3 . Cells were then filtered through a 100 mm mesh and counted using a Countless automated cell counter (Invitrogen). For phenotypic analysis, 1.5 × 10 7 cells were stained.
Flow cytometric analysis. Single-cell suspensions of the spleen and lymph nodes (pooled axillary, brachial, inguinal and mesenteric) were stained as described 1 with FITC-, R-PE-or APC-conjugated mAbs specific for mouse cell surface markers: RB6-8C5: anti-Gr-1, MI/70: anti-Mac-1, M3/84.6.34: anti-Mac-2, Ter119, F4/80, T24.31.2: anti-Thy-1, GK1.5: anti-CD4, 53.6.72: anti-CD8, RA3-6B2: anti-CD45R-B220 and PK136: anti-NK1.1 (BD Biosciences, Franklin Lakes, NJ, USA). The vital dye PI (1 μg/ml) was included and data were acquired on a FACScan (Becton Dickinson, Franklin Lakes, NJ, USA) or LSR II (Becton Dickinson). Tregs were detected after fixation and permeabilization (eBiosciences) by staining with anti-CD25-R-PE, anti-CD4-FITC and anti-Foxp3-APC antibodies, followed by data acquisition on a LSR II (Becton Dickson). Single-cell suspensions were prepared from the lungs by digestion for 20 min at room temperature with collagenase/DNAse (7 mg collagenase (Worthington, Lakewood, NJ, USA) in 1 ml volume of 0.1% w/v DNAse1 (Roche)) treated with EDTA as described, 55 and then stained with an R-PE-coupled antibody to Thy-1 plus a panel of biotinylated antibodies specific to different TCRVβ regions followed by staining with FITCcoupled streptavidin (BD-Pharmingen). Phenotypic analysis of thymic stromal cells by flow cytometry was performed using the following antibody conjugates: PerCP-cy5.5 anti-CD45.2 (clone 30F11, Biolegend, San Diego, CA, USA) and PE anti-Ly51 (Biolegend). APC anti-AIRE, FITC anti-MHC class II (H-2A/E, clone M5 114/15.2) and APC-cy7 anti-EpCAM (clone G8.8a) were produced in-house.
Measurement of serum immunoglobulin levels. Serum immunoglobulin levels were determined by ELISA using sheep anti-mouse Ig antibodies (Silenus Laboratories, Australia) as a capture reagent and developed with mouse Ig isotypespecific goat antibodies conjugated to horseradish peroxidase (Southern Biotechnology). Purified myeloma proteins were used as standards (Sigma, MO, USA).
Analysis of serum cytokine and chemokine levels. Cytokine and chemokine levels in sera were measured by using Bio-Plex Pro mouse cytokine 23-plex (Bio-Rad, Gladesville, NSW, Australia) and Bio-Plex Pro mouse cytokine Statistical analysis. Statistical analysis was performed using Student's t-test, log rank (Mantel-Cox) test for animal survival curves, one-way analysis of variance using Tukey's comparison test to compare multiple groups or the Mann-Whitney test where appropriate.
